What Processa Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 41 |
| Sells | 0 | 0 |
| Total trades | 1 | 50 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,600 | 83,176 |
| Disposed | 0 | 0 |
| Net activity | +1,600 | +83,176 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer | Aug 08 | Exercise / conversion · M | +1,600 | — | — | 17,092 |
| Ng George K | Chief Executive Officer | Jul 01 | Open-market buy · P | +3,057 | $1.93 | +$5.9K | 15,492 |
| Young David | Pres. Research & Development | Jun 30 | Open-market buy · P | +2,531 | $1.93 | +$4.88K | 21,729 |
| Skibsted Russell | Chief Financial Officer | Jun 30 | Open-market buy · P | +3,277 | $1.93 | +$6.32K | 16,689 |
| Lin Patrick | Chief Business - Strategy Off | Jun 30 | Open-market buy · P | +2,106 | $1.93 | +$4.06K | 13,113 |
| Guy Wendy | Chief Administrative Officer | Jun 30 | Open-market buy · P | +2,436 | $1.93 | +$4.7K | 14,394 |
| Baluch Khoso | Director | Jun 26 | Exercise / conversion · M | +203 | — | — | 2,528 |
| Neal James R | Director | Jun 26 | Exercise / conversion · M | +203 | — | — | 1,021 |
| Yorke Justin W | Director | Jun 26 | Exercise / conversion · M | +203 | — | — | 353 |
| Pannu Geraldine | Director | Jun 26 | Exercise / conversion · M | +203 | — | — | 2,391 |
| Guy Wendy | Chief Administrative Officer | Jun 15 | Open-market buy · P | +2,118 | $2.22 | +$4.7K | 11,958 |
| Skibsted Russell | Chief Financial Officer | Jun 15 | Open-market buy · P | +2,654 | $2.22 | +$5.89K | 13,412 |
| Lin Patrick | Chief Business - Strategy Off | Jun 15 | Open-market buy · P | +1,831 | $2.22 | +$4.06K | 11,007 |
| Ng George K | Chief Executive Officer | Jun 15 | Open-market buy · P | +2,465 | $2.22 | +$5.47K | 12,435 |
| Young David | Pres. Research & Development | Jun 15 | Open-market buy · P | +2,067 | $2.22 | +$4.59K | 19,198 |
| Ng George K | Chief Executive Officer | May 29 | Open-market buy · P | +2,129 | $2.57 | +$5.47K | 9,970 |
| Lin Patrick | Chief Business - Strategy Off | May 29 | Open-market buy · P | +1,582 | $2.57 | +$4.07K | 9,176 |
| Skibsted Russell | Chief Financial Officer | May 29 | Open-market buy · P | +2,292 | $2.57 | +$5.89K | 10,758 |
| Guy Wendy | Chief Administrative Officer | May 29 | Open-market buy · P | +1,829 | $2.57 | +$4.7K | 9,840 |
| Young David | Pres. Research & Development | May 29 | Open-market buy · P | +1,786 | $2.57 | +$4.59K | 17,131 |
Loading...